Taken together, these findings are supportive that the promotion of tamoxifen resistance in ER+ breast cancer through modulating the translation of the selective mRNAs mediated by eIF4E overexpression is independent of the phosphorylation status at S209. Here, EIF4E is linked to breast carcinoma.